MET

NEUTRALEarnings

MetLife, Inc.

2026-08-03

Price

$96.31

+0.19%

This is the 2026-08-03 snapshot — the signals and analysis for MET as of this single trading day.

View full MET research hub →

Score8.5Priority

Signals4/8 DNA0/13 Act · 1/4 Risk

SentimentNEUTRALScore: 8

Volume1.1xvs 20d avg

Analysis

MetLife (MET) is demonstrating High-Conviction Price Discovery as it heads into its Q2 2026 earnings print on August 5th. The stock's 12% monthly surge and robust technical signals (ALPHA_MALE, PERFECT_STACK) reflect aggressive institutional accumulation rather than passive drifting. This price action is fully validated by the current RISK_ON (EARNINGS) macro regime, where tight credit spreads (0.80%) and a stable VIX (16.0) provide a highly supportive backdrop for financial equities. The market is confidently pricing in a strong quarter, likely driven by strength in the Group Benefits segment.

Fired Signals

ALPHA MALESTEADY CLIMBGOLDEN CROSSPERFECT STACKDISTRIBUTION

Key Takeaways

Actionable Thesis: Institutional accumulation is evident ahead of the August 5th Q2 earnings release [1.1.8], supported by high relative strength (+11.1% vs SPY) and robust technical signals.
Key Risk: A miss on the $2.30 EPS consensus or weak Group Benefits revenue could trigger a sharp mean-reversion given the recent 12% run.
What to Watch: Price response around the $87.20 support level and management's commentary on commercial real estate exposure and alternative investment returns.

← Back to 2026-08-03 View Full MET History →Yahoo Finance &nearr;